KEY PRODUCTS
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
01 1Fareva
01 1NORETHINDRONE ACETATE
01 1Luxembourg
01 1Active
01 1Complete
Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-02
Pay. Date : 2013-09-18
DMF Number : 24913
Submission : 2011-05-25
Status : Active
Type : II
20
Valdepharm, based in Luxembourg, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
One of their notable products is NORETHINDRONE ACETATE, with a corresponding US DMF Number 24913.
Remarkably, this DMF maintains an Active status since its submission on May 25, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2014, and payment made on September 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
